# Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

> **NCT04938869** · NA · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Educational Intervention
- **OTHER:** Medical Device Usage and Evaluation
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04938869
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-05
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-02-17
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938869, "Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04938869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*